Use of Monoclonal Antibodies in Cloning and Identification of Membrane Antigens

Since their discovery, monoclonal antibodies (mAbs) have been looked at as very promising tools to diagnose and possibly treat human tumors. For that reason many mAbs have been developed to identify antigens on the surface of cells that are specific for cancer or that are at least expressed in larger amounts on tumor cells than on normal cells.